Source comparison
Melanotan-2 Freckles vs Sun Freckles: Comparison
Formation Mechanism MC1R receptor overstimulation in areas with pre-existing melanocyte clusters; triggered by systemic peptide administration UV-induced localised α-MSH release from keratinocytes, activating melanocytes in sun-exposed areas only Melanotan-2 p
This comparison does not assign a generated winner or score.
- Formation Mechanism
- MC1R receptor overstimulation in areas with pre-existing melanocyte clusters; triggered by systemic peptide administration
- UV-induced localised α-MSH release from keratinocytes, activating melanocytes in sun-exposed areas only
- Melanotan-2 produces more uniform spatial distribution but greater pigment intensity per lesion due to systemic receptor activation
- Onset Timeline
- 7–14 days from first injection; accelerates during dose escalation
- Gradual development over weeks to months of cumulative UV exposure
- Peptide-induced freckles appear faster because receptor saturation is immediate and sustained
- Reversibility
- Partial fading over 3–6 months post-cessation; residual pigment often persists in previously sun-damaged areas
- Fade partially with UV avoidance but rarely resolve completely without intervention
- Both types are driven by permanent melanocyte presence; neither fully reverses without depigmentation treatments
- Correlation with Skin Type
- Highest incidence in Fitzpatrick I-II (MC1R variant carriers); rare in types IV-VI
- Primarily affects types I-III; minimal in darker constitutive skin tones
- Genetic MC1R polymorphisms predict melanotan-2 freckle risk more reliably than sun freckle risk
- Prevention Strategy
- Slow dose titration (50–100mcg daily start) + UV avoidance during loading phase
- Broad-spectrum SPF 30+ and UV avoidance
- Melanotan-2 freckles are preventable through protocol modification; sun freckles require strict photoprotection